South Wales, Dec. 1 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "LYRZO" on Nov. 18. The details about the trademark application no. UK00004296491 published in the journal no. 2025/048 (Nov. 28).
With Carpmaels & Ransford LLP as representative, AbbVie Inc. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004296491
Disclaimer: Curated by HT Syndication.